Kiora Pharmaceuticals (KPRX) EPS (Basic) (2014 - 2026)
Kiora Pharmaceuticals' (KPRX) quarterly EPS (Basic) came in at -$0.58 in Q1 2026, down 11.37% YoY from -$0.65 in Q1 2025, and up 62.97% on a QoQ basis from -$1.56 in Q4 2025.
Kiora Pharmaceuticals (KPRX) EPS (Basic) (2014 - 2026) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 13 years of EPS (Basic) data on file, last reported at -$0.58 in Q1 2026.
- Quarterly EPS (Basic) fell 11.37% year-over-year to -$0.58 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.65 (up 7.3% YoY) and the FY2025 annual result came in at -$2.6, down 380.15% from the prior year.
- EPS (Basic) grew to -$0.58 in Q1 2026, from -$1.56 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $4.67 in Q1 2024 to a low of -$99.93 in Q1 2022.
- A 5-year average of -$16.8 and a median of -$1.56 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) plunged 2176.67% — and 2024, when it soared 150.41%.
- Tracing KPRX's EPS (Basic) over 5 years: stood at -$30.71 in 2022, then soared by 86.27% to -$4.22 in 2023, then surged by 74.14% to -$1.09 in 2024, then slumped by 43.4% to -$1.56 in 2025, then jumped by 62.97% to -$0.58 in 2026.
- The last three EPS (Basic) figures came in at -$0.58 (Q1 2026), -$1.56 (Q4 2025), and $0.01 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Kiora Pharmaceuticals | 16.25 Mn | 16.25 Mn | - | -0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.34 |
| Mar 31, 2026 | -0.58 |
| Dec 31, 2025 | -1.56 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | -0.54 |
| Mar 31, 2025 | -0.52 |
| Dec 31, 2024 | -1.09 |
| Sep 30, 2024 | -0.81 |
| Jun 30, 2024 | -0.53 |
| Mar 31, 2024 | 4.67 |
| Dec 31, 2023 | -4.22 |
| Sep 30, 2023 | -7.97 |
| Jun 30, 2023 | -7.31 |
| Mar 31, 2023 | -9.26 |
| Dec 31, 2022 | -30.71 |
| Sep 30, 2022 | -54.30 |
| Jun 30, 2022 | -71.02 |
| Mar 31, 2022 | -99.93 |
| Dec 31, 2021 | -560.69 |
| Sep 30, 2021 | -2.39 |